Abstract
A drug requires a suitable pharmacokinetic profile to be efficacious in vivo in humans. The relevant pharmacokinetic properties include the absorption, distribution, metabolism, and excretion (ADME) profile of the drug. This chapter provides an overview of the definition and meaning of key ADME properties, recent models developed to predict these properties, and a guide as to how to select the most appropriate model(s) for a given query. Many tools using the state-of-the-art in silico methodology are now available to users, and it is anticipated that the continual evolution of these tools will provide greater ability to predict ADME properties in the future. However, caution must be exercised in applying these tools as data are generally available only for “successful” drugs, i.e., those that reach the marketplace, and little supplementary information, such as that for drugs that have a poor pharmacokinetic profile, is available. The possibilities of using these methods and possible integration into toxicity prediction are explored.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
REFERENCES
Kerns EH, Di L (2008) Drug-like properties: Concepts, structure design and methods. Elsevier, Burlington, USA
d’Yvoire MB, Prieto P, Blaauboer BJ et al. (2007) Physiologically-based kinetic modelling (PBK modelling): Meeting the 3Rs agenda. The report and recommendations of ECVAM workshop 63. ATLA 35:661–671
Szakacs G, Varadi A, Ozvegy-Laczka C, Sarkadi B (2008) The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). DDT 13:379–393
Wilkinson GG (2001) Pharmacokinetics: The dynamics of drug absorption, distribution and elimination. In: Hardman J, Limbird E (eds) Goodman and Gilman’s the pharmacological basis of therapeutics, McGraw-Hill, New York, pp 3–29
Gibbs S, van de Sandt JJM, Merk HF et al. (2007) Xenobiotic metabolism in human skin and 3-D human constructs: A review. Curr Drug Metab 8:758–772
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3–25
Lobell M, Hendrix M, Hinzen B, Keldenrich J (2006) In Silico ADMET traffic lights as a tool for the prioritization of HTS hits. Chem Med Chem 1:1229–1236
Gleeson MP (2008) Generation of a set of simple, interpretable ADMET rules of thumb. J Med Chem 51:817–834
Hou T, Wang J, Zhang W et al. (2006) Recent advances in computational prediction of drug absorption and permeability in drug discovery. Curr Med Chem 13:2653–2667
Lian G, Chen L, Han L (2008) An evaluation of mathematical models for predicting skin permeability. J Pharm Sci 97:584–598
Basak SC, Mills D Mumtaz MM (2007) A quantitative structure-activity relationship (QSAR) study of dermal absorption using theoretical molecular descriptors. SAR QSAR Env Res 18:45–55
Veber DF, Johnson SR, Cheng H-Y et al. (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615–2623
Moda TL, Monanari CA, Andricopulo AD (2007) Hologram QSAR model for the prediction of human oral bioavailability. Bioorg Med Chem 15:7738–7745
Colmenarejo G (2003) In silico prediction of drug-binding strengths to human serum albumin. Med Res Rev 23:275–301
Votano JR, Parham M, Hall ML et al. (2006) QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation. J Med Chem 49:7169–7181
Ghafourian T, Barzegar-Jalali M, Hakimiha N et al. (2004) Quantitative structure-pharmacokinetic relationship modelling: apparent volume of distribution. J Pharm Pharmacol 56:339–350
Lombardo F, Obach RS, Shalaeva MY, Gao F (2004) Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. J Med Chem 47:1242–1250
Gleeson MP, Waters NJ, Paine SW et al. (2006) In silico human and rat Vss quantitative structure-activity relationship models. J Med Chem 49:1953–1963
Sui XF, Sun J, Wu X et al. (2008) Predicting the volume of distribution of drugs in humans. Curr Drug Metab 9:574–580
Zhang H (2005) A new approach for the tissue-blood partition coefficients of neutral and ionized compounds. J Chem Inf Model 45:121–127
Abraham MH, Ibrahim A, Acree WE Jr (2006) Air to brain, blood to brain and plasma to brain distribution of volatile organic compounds: linear free energy analyses. Eur J Med Chem 41:494–502
Basak SC, Mills D, Gute BD (2006) Prediction of tissue–air partition coefficients – theoretical vs experimental methods. QSAR SAR Env Res 17:515–532
Norinder U, Haberlein M (2002) Computational approaches to the prediction of the blood-brain distribution. Adv Drug Deliv Rev 54:291–313
Konovalov DA, Coomans D, Deconinck E, Heyden YV (2007) Benchmarking of QSAR models for blood-brain barrier permeation. J Chem Inf Model 47:1648–1656
Li H, Yap CW, Ung CY et al. (2005) Effect of selection of molecular descriptors on the prediction of blood brain barrier penetrating and nonpenetrating agents by statistical learning methods. J Chem Inf Model 45:1376–1384
Zhao YH, Abraham MH, Ibrahim A et al. (2007) Predicting penetration across the blood-brain barrier from simple descriptors and fragmentation schemes. J Chem Inf Model 47:170–175
Hewitt M, Madden JC, Rowe PH, Cronin MTD (2007) Structure-based modelling in reproductive toxicology: (Q)SARs for the placental barrier. SAR QSAR Env Res 18:57–76
Chang C, Ray A, Swaan P (2005) In Silico strategies for modeling membrane transporter function. DDT 10:663–671
Huang J, Ma G, Muhammad I, Cheng Y (2007) Identifying P-glycoprotein substrates using a support vector machine optimised by a particle swarm. J Chem Inf Mod 47:1638–1647
Cabrera MA, Gonzalez I, Fernandez C et al. (2006) A topological substructural approach for the prediction of P-glycoprotein substrates. J Pharm Sci 95:589–606
Manga N, Duffy JC, Rowe PH, Cronin MTD (2003) A hierarchical QSAR model for urinary excretion of drugs in humans as a predictive tool for biotransformation. QSAR Comb Sci 22:263–273
Agatonovic-Kustrin S, Ling LH, Tham SY, Alany RG (2002) Molecular descriptors that influence the amount of drugs transfer into human breast milk. J Pharm Biomed Anal 29:103–119
Afzelius L, Arnby CH, Broo A et al. (2007) State-of-the-art tools for computational site of metabolism predictions: comparative analysis, mechanistical insights, and future applications. Drug Metab Rev 39:61–86
Madden JC, Cronin MTD (2006) Structure-based methods for the prediction of drug metabolism. Expert Opin Drug Metab Toxicol 2:545–557
Payne M (2004) Computer-based methods for the prediction of chemical metabolism and biotransformation within biological organisms. In: Cronin MTD, Livingstone DJ (eds) Predicting chemical toxicity and fate. CRC Press, Boca Raton
Manga N, Duffy JC, Rowe PH, Cronin MTD (2005) Structure-based methods for the prediction of the dominant P450 enzyme in human drug biotransformation: Consideration of CYP3A4, CYP2C9, CYP2D6. SAR QSAR Env Res 16:43–61
Yap CW, Li ZR, Chen YZ (2006) Quantitative structure-pharmacokinetic relationships for drug clearance by using statistical learning methods. J Mol Graph Mod 24:383–395
Quinones C, Caceres J, Stud M, Martinez A (2000) Prediction of drug half-life values of anti-histamines based on the CODES/neural network model. Quant Struct Act Relat 19:448–454
Quinones-Torrelo C, Sagrado S, Villaneuva-Camanas RM, Medina-Hernandez MJ (2001) Retention pharmacokinetic and pharmacodynamic parameter relationships of antihistmaine drugs using biopartitioning micellar chromatography. J Chromatogr B 761:13–26
Netzeva TI, Worth AP, Aldenberg T et al. (2005) Current status of methods for defining the applicability domain of (quantitative) structure–activity relationships. The report and recommendations of ECVAM Workshop 52. ATLA 33:155–173
Hou T, Wang J, Zhang W, Xu X (2007) ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classification. J Chem Inf Model 47:208–218
Hou T, Wang J, Zhang W, Xu X (2007) ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules. J Chem Inf Model 47:460–463
Abraham MH, Ibrahim A, Zhao Y, Acree WE Jr (2006) A database for partition of volatile organic compounds and drugs from blood/plasma/serum to brain and an LFER analysis of the data. J Pharm Sci 95:2091–2100
Kalgutkar AS, Gardner I, Obach S et al. (2005) A comprehensive listing of bioactivation pathways of organic functional groups. Curr Drug Metab 6:161–225
Turner JV, Maddalena DJ, Cutler DJ (2004) Pharmacokinetic parameter prediction from drug structure using artificial neural networks. Int J Pharmac 270:209–219
Takano M, Yumoto R, Murakami T (2006) Expression and function of efflux transporters in the intestine. Pharmacol Ther 109:137–161
Thummel KE, Shen GG (2001) Design and optimization of dosage regimens: Pharmacokinetic data. In: Hardman J, Limbird E (eds) Goodman and Gilman’s the pharmacological basis of therapeutics. McGraw-Hill, New York, pp 1917–2023
Schultz M, Schmoldt A (1997) Therapeutic and toxic blood concentrations of more than 500 drugs. Pharmazie 52(12):895–911
Hollósy F, Valkó K, Hersey A et al. (2006) Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilised artificial membrane partitioning. J Med Chem 49:6958–6971
Ekins S (2006) Systems-ADME/Tox: Resources and network approaches. J Pharmacol Toxicol Meth 53:38–66
de Groot M (2006) Designing better drugs: Predicting cytochrome P450 metabolism. Drug Disc Today 11:601–606
Banik GM (2004) In silico ADME-Tox prediction: the more the merrier. Curr Drug Disc 4:31–34
Ekins S, Waller CL, Swann PW (2000) Progress in predicting human ADME parameters in silico. J Pharmacol Toxicol Meth 44:251–272
Duffy JC (2004) Prediction of pharmacokinetic parameters in drug design and toxicology. In: Cronin MTD, Livingstone DJ (eds) Predicting chemical toxicity and fate. CRC Press, Boca Raton
Gola J, Obrezanova O, Champness E, Segall M (2006) ADMET property prediction: The state of the art and current challenges. QSAR Comb Sci 25:1172–1180
Chohan KK, Paine SW, Water, NJ (2006) Quantitative structure activity relationships in drug metabolism. Curr Top Med Chem 6:1569–1578
Winkler DA (2004) Neural networks in ADME and toxicity prediction. Drugs Fut 29:1043–1057
Dearden JC (2007) In silico prediction of ADMET properties: How far have we come? Expert Opin Drug Metab Toxicol 3:635–639
Enoch SJ, Cronin MTD, Schultz TW, Madden JC (2008) An evaluation of global QSAR models for the prediction of the toxicity of phenols to Tetrahymena pyriformis. Chemosphere 71:1225–1232
Rodgers SL, Davis AM, van de Waterbeemd H (2007) Time-series QSAR analysis of human plasma protein binding data. QSAR Comb Sci 26:511–521
Ekins S, Andreyev S, Ryabov A et al. (2005) Computational prediction of human drug metabolism. Expert Opin Drug Metab Toxicol 1:303–324
Stouch TR, Kenyon JR, Johnson SR et al. (2003) In Silico ADME/Tox: Why models fail. J Comput-Aid Mol Des 17:83–92
Jamei M, Marciniak S, Feng K (2009) The Simcyp® population based ADME simulator. Expert Opin Drug Metab Toxicol 5:211–223
Acknowledgement
The funding of the European Union 6th Framework CAESAR Specific Targeted Project (SSPI-022674-CAESAR) and OSIRIS Integrated Project (GOCE-037017-OSIRIS) is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Madden, J.C. (2010). In Silico Approaches for Predicting Adme Properties. In: Puzyn, T., Leszczynski, J., Cronin, M. (eds) Recent Advances in QSAR Studies. Challenges and Advances in Computational Chemistry and Physics, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9783-6_10
Download citation
DOI: https://doi.org/10.1007/978-1-4020-9783-6_10
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-9782-9
Online ISBN: 978-1-4020-9783-6
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)